Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
20 Mar 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/with-fast-track-designation-in-hand-a-successful-protocol-discussion-1001827
10 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/10/3039710/0/en/Biodexa-Announces-Successful-Outcome-of-a-Type-C-Meeting-with-FDA-Regarding-the-Phase-3-Program-for-eRapa-in-FAP.html
06 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/06/3038182/0/en/Biodexa-Announces-Appointment-of-Precision-for-Medicine-LLC-as-CRO-for-European-Component-of-Phase-3-Study-of-eRapa-in-FAP.html
24 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/24/3031130/0/en/Biodexa-Announces-Allowance-of-U-S-Patent-Covering-Oral-Rapamycin-Nanoparticle-Preparations-eRapa-and-Use.html
13 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/13/3025869/0/en/Biodexa-Pharmaceuticals-PLC-to-Present-at-the-Emerging-Growth-Conference-on-February-19-2025.html
12 Feb 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/following-positive-phase-2-results-and-orphan-drug-designation-biodexa-983495
ABOUT THIS PAGE